Breast CAncer

Exercise Habit Prior to Breast Cancer Chemo May Aid Cognition

Publish Date September 10, 2021

Adherence to physical activity guidelines throughout chemotherapy was associated with better self-reported cognition.

Study Identified Prognostic Factors for OS With Palbociclib in Advanced Breast Cancer

By

Vicki Moore, PhD

Publish Date September 9, 2021

Researchers identified prognostic factors for improved overall survival in patients treated with palbociclib and fulvestrant for advanced breast cancer.

Group Releases Data Set for Artificial Intelligence Research in Breast Cancer

By

Sucharita Mistry, PhD

Publish Date September 7, 2021

Editorialists questioned the quality of the data set.

Tecentriq Indication for Triple-Negative Breast Cancer Withdrawn

By

Brian Park, PharmD

Publish Date August 31, 2021

In 2019, the FDA granted accelerated approval to Tecentriq, a PD-L1 blocking antibody, for unresectable locally advanced or metastatic TNBC.

Breast Cancer Screening Down Among Low-Income Women During Pandemic

Publish Date August 30, 2021

Eight percent drop in screenings at 32 community health centers means about 47,517 fewer mammograms, 242 missed breast cancer diagnoses

Screening Mammograms Plummeted During COVID-19 Pandemic

Publish Date August 23, 2021

Drop in breast cancer screenings at one safety-net hospital raises concerns for worsening of preexisting health disparities.

Predictive Models May Reduce False-Positive Results of Breast Cancer Screening

By

Jonathan Goodman, MPhil

Publish Date August 23, 2021

Both models would have reduced false positives without missing any cancer cases.

Study Supports Early Breast Cancer Screening in Childhood Cancer Survivors Not Treated With Radiation

By

Sucharita Mistry, PhD

Publish Date August 18, 2021

Starting screening at age 40 was linked to a reduced risk of death and was deemed cost-effective.

Entinostat Does Not Overcome Endocrine Resistance in Advanced Breast Cancer

By

Sucharita Mistry, PhD

Publish Date August 17, 2021

Entinostat did not improve progression-free or overall survival.

Incidence of Axillary Adenopathy After COVID-19 Vaccination May Be Lower Than Previously Thought

By

Leah Lawrence

Publish Date August 9, 2021

Prior data suggested the incidence may be as high as 16%.